{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:02:12Z","timestamp":1789614132599,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1124\/mol.111.072249","type":"journal-article","created":{"date-parts":[[2011,7,8]],"date-time":"2011-07-08T14:48:27Z","timestamp":1310136507000},"page":"610-620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"title":["The Selective Estrogen Receptor Modulator Bazedoxifene Inhibits Hormone-Independent Breast Cancer Cell Growth and Down-Regulates Estrogen Receptor \u03b1 and Cyclin D1"],"prefix":"10.1016","volume":"80","author":[{"given":"Joan S.","family":"Lewis-Wambi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Curpan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Grigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed A.","family":"Sarker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Craig","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.111.072249_bib1","doi-asserted-by":"crossref","first-page":"23589","DOI":"10.1074\/jbc.270.40.23589","article-title":"Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions","volume":"270","author":"Albanese","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.111.072249_bib2","first-page":"2315","article-title":"17beta-Estradiol induces cyclin D1 gene transcription, p36D1\u2013p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells","volume":"12","author":"Altucci","year":"1996","journal-title":"Oncogene"},{"key":"10.1124\/mol.111.072249_bib3","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/gme.0b013e3181a818db","article-title":"Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women","volume":"16","author":"Archer","year":"2009","journal-title":"Menopause"},{"key":"10.1124\/mol.111.072249_bib4","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1158\/0008-5472.CAN-09-3068","article-title":"The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells","volume":"70","author":"Ariazi","year":"2010","journal-title":"Cancer Res"},{"key":"10.1124\/mol.111.072249_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/mol.111.072249_bib6","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1073\/pnas.86.4.1218","article-title":"Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence","volume":"86","author":"Berry","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.111.072249_bib7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/39645","article-title":"Molecular basis of agonism and antagonism in the oestrogen receptor","volume":"389","author":"Brzozowski","year":"1997","journal-title":"Nature"},{"key":"10.1124\/mol.111.072249_bib8","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J Med Chem"},{"key":"10.1124\/mol.111.072249_bib9","doi-asserted-by":"crossref","first-page":"8000","DOI":"10.1158\/1078-0432.CCR-08-0975","article-title":"Genetic susceptibility loci for breast cancer by estrogen receptor status","volume":"14","author":"Garcia-Closas","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1124\/mol.111.072249_bib10","doi-asserted-by":"crossref","first-page":"e1000054","DOI":"10.1371\/journal.pgen.1000054","article-title":"Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics","volume":"4","author":"Garcia-Closas","year":"2008","journal-title":"PLoS Genet"},{"key":"10.1124\/mol.111.072249_bib11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jmb.2003.11.016","article-title":"Computational modeling of the catalytic reaction in triosephosphate isomerase","volume":"337","author":"Guallar","year":"2004","journal-title":"J Mol Biol"},{"key":"10.1124\/mol.111.072249_bib12","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/jnci\/84.8.580","article-title":"Growth regulation of estrogen receptor-negative breast cancer cells transfected with complementary DNAs for estrogen receptor","volume":"84","author":"Jiang","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/mol.111.072249_bib13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0303-7207(92)90104-E","article-title":"An estrogen receptor positive MCF-7 clone that is resistant to antiestrogens and estradiol","volume":"90","author":"Jiang","year":"1992","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/mol.111.072249_bib14","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.steroids.2007.07.009","article-title":"New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer","volume":"72","author":"Jordan","year":"2007","journal-title":"Steroids"},{"key":"10.1124\/mol.111.072249_bib15","first-page":"3073","article-title":"The 38th David A","volume":"26","author":"Jordan","year":"2008","journal-title":"Karnofsky lecture: the paradoxical actions of estrogen in breast cancer\u2013survival or death? J Clin Oncol"},{"key":"10.1124\/mol.111.072249_bib16","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1158\/0008-5472.CAN-09-0029","article-title":"A century of deciphering the control mechanisms of sex steroid action in breast and prostate cancer: the origins of targeted therapy and chemoprevention","volume":"69","author":"Jordan","year":"2009","journal-title":"Cancer Res"},{"key":"10.1124\/mol.111.072249_bib17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/gme.0b013e3181b7c65f","article-title":"A randomized, placebo- and active-controlled trial of bazedoxifene\/conjugated estrogens for treatment of moderate to severe vulvar\/vaginal atrophy in postmenopausal women","volume":"17","author":"Kagan","year":"2010","journal-title":"Menopause"},{"key":"10.1124\/mol.111.072249_bib18","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1210\/en.2005-0030","article-title":"Bazedoxifene acetate: a selective estrogen receptor modulator with improved selectivity","volume":"146","author":"Komm","year":"2005","journal-title":"Endocrinology"},{"key":"10.1124\/mol.111.072249_bib19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0003-2697(80)90165-7","article-title":"A simple, rapid, and sensitive DNA assay procedure","volume":"102","author":"Labarca","year":"1980","journal-title":"Anal Biochem"},{"key":"10.1124\/mol.111.072249_bib20","first-page":"413","article-title":"Chromosome 11q13 abnormalities in human cancer","volume":"3","author":"Lammie","year":"1991","journal-title":"Cancer Cells"},{"key":"10.1124\/mol.111.072249_bib21","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.ejca.2008.05.016","article-title":"Overexpression of CEACAM6 promotes migration and invasion of oestrogen-deprived breast cancer cells","volume":"44","author":"Lewis-Wambi","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1124\/mol.111.072249_bib22","doi-asserted-by":"crossref","first-page":"R104","DOI":"10.1186\/bcr2208","article-title":"Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis","volume":"10","author":"Lewis-Wambi","year":"2008","journal-title":"Breast Cancer Res"},{"key":"10.1124\/mol.111.072249_bib23","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1093\/jnci\/dji400","article-title":"Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation","volume":"97","author":"Lewis","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/mol.111.072249_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jsbmb.2004.12.032","article-title":"Estrogen-induced apoptosis in a breast cancer model resistant to long-term estrogen withdrawal","volume":"94","author":"Lewis","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1124\/mol.111.072249_bib25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1677\/jme.1.01599","article-title":"Differential effects of 16alpha-hydroxyestrone and 2-methoxyestradiol on cyclin D1 involving the transcription factor ATF-2 in MCF-7 breast cancer cells","volume":"34","author":"Lewis","year":"2005","journal-title":"J Mol Endocrinol"},{"key":"10.1124\/mol.111.072249_bib26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3727\/096504005776367924","article-title":"Activation of cyclin D1 by estradiol and spermine in MCF-7 breast cancer cells: a mechanism involving the p38 MAP kinase and phosphorylation of ATF-2","volume":"15","author":"Lewis","year":"2005","journal-title":"Oncol Res"},{"key":"10.1124\/mol.111.072249_bib27","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1021\/jm901907u","article-title":"Structure-function relationships of estrogenic triphenylethylenes related to endoxifen and 4-hydroxytamoxifen","volume":"53","author":"Maximov","year":"2010","journal-title":"J Med Chem"},{"key":"10.1124\/mol.111.072249_bib28","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1021\/jm010086m","article-title":"Design, synthesis, and preclinical characterization of novel, highly selective indole estrogens","volume":"44","author":"Miller","year":"2001","journal-title":"J Med Chem"},{"key":"10.1124\/mol.111.072249_bib29","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1359\/jbmr.071206","article-title":"Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study","volume":"23","author":"Miller","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1124\/mol.111.072249_bib30","first-page":"7285","article-title":"Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions","volume":"50","author":"Murphy","year":"1990","journal-title":"Cancer Res"},{"key":"10.1124\/mol.111.072249_bib31","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/bjc.1996.521","article-title":"Irreversible loss of the oestrogen receptor in T47D breast cancer cells following prolonged oestrogen deprivation","volume":"74","author":"Pink","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1124\/mol.111.072249_bib32","first-page":"2583","article-title":"An estrogen-independent MCF-7 breast cancer cell line which contains a novel 80-kilodalton estrogen receptor-related protein","volume":"55","author":"Pink","year":"1995","journal-title":"Cancer Res"},{"key":"10.1124\/mol.111.072249_bib33","first-page":"2321","article-title":"Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines","volume":"56","author":"Pink","year":"1996","journal-title":"Cancer Res"},{"key":"10.1124\/mol.111.072249_bib34","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/gme.0b013e3181a816be","article-title":"Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis","volume":"16","author":"Pinkerton","year":"2009","journal-title":"Menopause"},{"key":"10.1124\/mol.111.072249_bib35","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/endo.138.9.5436","article-title":"Progesterone, in addition to estrogen, induces cyclin D1 expression in the murine mammary epithelial cell, in vivo","volume":"138","author":"Said","year":"1997","journal-title":"Endocrinology"},{"key":"10.1124\/mol.111.072249_bib36","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0092-8674(00)81717-1","article-title":"The structural basis of estrogen receptor\/coactivator recognition and the antagonism of this interaction by tamoxifen","volume":"95","author":"Shiau","year":"1998","journal-title":"Cell"},{"key":"10.1124\/mol.111.072249_bib37","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1359\/jbmr.080710","article-title":"Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial","volume":"23","author":"Silverman","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1124\/mol.111.072249_bib38","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1006\/scbi.2001.0389","article-title":"Estrogen receptor and breast cancer","volume":"11","author":"Sommer","year":"2001","journal-title":"Semin Cancer Biol"},{"key":"10.1124\/mol.111.072249_bib39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1023\/B:JOMG.0000023591.45568.77","article-title":"Cyclins and breast cancer","volume":"9","author":"Sutherland","year":"2004","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10.1124\/mol.111.072249_bib40","doi-asserted-by":"crossref","first-page":"21862","DOI":"10.1074\/jbc.M200764200","article-title":"Interaction of transcriptional intermediary factor 2 nuclear receptor box peptides with the coactivator binding site of estrogen receptor alpha","volume":"277","author":"W\u00e4rnmark","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.111.072249_bib41","first-page":"849","article-title":"Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogens","volume":"3","author":"Wilcken","year":"1997","journal-title":"Clin Cancer Res"},{"key":"10.1124\/mol.111.072249_bib42","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1158\/0008-5472.CAN-08-3933","article-title":"The tamoxifen metabolite, endoxifen, is a potent antiestrogen that targets estrogen receptor alpha for degradation in breast cancer cells","volume":"69","author":"Wu","year":"2009","journal-title":"Cancer Res"},{"key":"10.1124\/mol.111.072249_bib43","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0092-8674(00)81879-6","article-title":"CDK-independent activation of estrogen receptor by cyclin D1","volume":"88","author":"Zwijsen","year":"1997","journal-title":"Cell"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24032991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24032991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.111.072249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:37:35Z","timestamp":1739961455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24032991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0026895X24032991"],"URL":"https:\/\/doi.org\/10.1124\/mol.111.072249","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Selective Estrogen Receptor Modulator Bazedoxifene Inhibits Hormone-Independent Breast Cancer Cell Growth and Down-Regulates Estrogen Receptor \u03b1 and Cyclin D1","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.111.072249","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}